These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31219627)

  • 41. Dangerous Abuse of a 40-Year-Old Over-the-Counter Medication, Loperamide.
    Shastay A
    Home Healthc Now; 2020; 38(3):167-168. PubMed ID: 32358446
    [No Abstract]   [Full Text] [Related]  

  • 42. Loperamide Induced Life Threatening Ventricular Arrhythmia.
    Upadhyay A; Bodar V; Malekzadegan M; Singh S; Frumkin W; Mangla A; Doshi K
    Case Rep Cardiol; 2016; 2016():5040176. PubMed ID: 27547470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Review: Loperamide Toxicity.
    Wu PE; Juurlink DN
    Ann Emerg Med; 2017 Aug; 70(2):245-252. PubMed ID: 28506439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity.
    Guinchat V; Ansermot N; Ing Lorenzini K; Politis D; Daali Y; Eap CB; Crettol S
    Front Psychiatry; 2022; 13():910684. PubMed ID: 35815036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loperamide, the "Poor Man's Methadone": Brief Review.
    Stanciu CN; Gnanasegaram SA
    J Psychoactive Drugs; 2017; 49(1):18-21. PubMed ID: 27918873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Additional Clinical Scenario of Risk for Loperamide Cardiac-Induced Toxicity.
    Hurtado-Torres GF; Sandoval-Munro RL
    Am J Med; 2016 Apr; 129(4):e33. PubMed ID: 26972143
    [No Abstract]   [Full Text] [Related]  

  • 47. Methadone Management of Withdrawal Associated With Loperamide-related Opioid Use Disorder.
    Leo RJ; Ghazi MA; Jaziri KS
    J Addict Med; 2017; 11(5):402-404. PubMed ID: 28574864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissociation between opiate-like and antidiarrheal activities of antidiarrheal drugs.
    Niemegeers CJ; McGuire JL; Heykants JJ; Janssen PA
    J Pharmacol Exp Ther; 1979 Sep; 210(3):327-33. PubMed ID: 480185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological Aspects of Over-the-Counter Opioid Drugs Misuse.
    Sobczak Ł; Goryński K
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loperamide-Induced Torsades de Pointes.
    Isang E; Shali L; Morris CB; Mahlow J
    Cureus; 2021 Dec; 13(12):e20299. PubMed ID: 35028205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loperamide: A Readily Available but Dangerous Opioid Substitute.
    White CM
    J Clin Pharmacol; 2019 Sep; 59(9):1165-1169. PubMed ID: 31116446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus.
    Mackerer CR; Brougham LR; East PF; Bloss JL; Dajani EZ; Clay GA
    J Pharmacol Exp Ther; 1977 Dec; 203(3):527-38. PubMed ID: 200732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loperamide poisoning in the dog.
    Hugnet C; Cadore JL; Buronfosse F; Pineau X; Mathet T; Berny PJ
    Vet Hum Toxicol; 1996 Feb; 38(1):31-3. PubMed ID: 8825747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence.
    Saucier R; Wolfe D; Dasgupta N
    Drug Saf; 2018 Oct; 41(10):981-988. PubMed ID: 29560596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loperamide: a pharmacological review.
    Baker DE
    Rev Gastroenterol Disord; 2007; 7 Suppl 3():S11-8. PubMed ID: 18192961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ventricular fibrillation due to overdose of loperamide, the "poor man's methadone".
    Salama A; Levin Y; Jha P; Alweis R
    J Community Hosp Intern Med Perspect; 2017 Oct; 7(4):222-226. PubMed ID: 29046747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loperamide-induced ventricular tachycardia storm.
    Daoub M; Cawley P; Sahu J
    Br J Cardiol; 2021; 28(4):46. PubMed ID: 35747063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased drug delivery to the brain by P-glycoprotein inhibition.
    Sadeque AJ; Wandel C; He H; Shah S; Wood AJ
    Clin Pharmacol Ther; 2000 Sep; 68(3):231-7. PubMed ID: 11014404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.
    Grover JM; Alabdrabalnabi T; Patel MD; Bachman MW; Platts-Mills TF; Cabanas JG; Williams JG
    Prehosp Emerg Care; 2018; 22(3):281-289. PubMed ID: 29297739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Labeling and Drug Safety Communication Approaches to Loperamide Abuse.
    Woronow D; Swank KA; Wu E; Kortepeter C; Levin RL
    JACC Clin Electrophysiol; 2017 Apr; 3(4):422. PubMed ID: 29759458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.